Number of COVID-19 infections continues to increase 1,329 new COVID-19 infections were reported over the past week. That is 342 more confirmed cases reported than the week before that, when 987 new COVID-19 infections were reported.
Number of COVID-19 infections is increasing 987 new COVID-19 infections were reported over the past week. This is nearly twice the number of infections reported in the previous week, when 534 new cases were reported.
Gap between intention and behaviour in staying home and testing for COVID-19 The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.
About 100 COVID-19 infections detected per week through source and contact tracing The results of 14 days of monitoring of source and contact tracing are known for week 26 (22 to 28 June).
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.
Release of QMRAspot v2 for quantitative microbial risk assessment of drinking water RIVM has developed a new version of QMRAspot (2.0), a user-friendly computational tool to calculate the risk of becoming infected by pathogenic microorganisms in drinking water.
Annoyance and health effects due to European transportation noise At least 20 million adults in Europe are annoyed by transportation noise in agglomerations, from motorways, airports or railways.
Statistical Program to Assess Dietary Exposure now available The Statistical Program to Assess Dietary Exposure (SPADE), developed by RIVM, is now available.
Information about medicines more accessible to the user The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w